Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Repaglinide X vs Novonorm in Type 2 Diabetes Mellitus
NCT00336310Phase 4Unknown
- Sponsor
- National Cheng Kung University Hospital
- Start
- Jul 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of repaglinide in type 2 diabetes mellitus (T2DM), sponsored by National Cheng Kung University Hospital. Status: unknown.
02
Drugs
repaglinide
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT00336310.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00336310.